Glazer Capital LLC’s Nexvet Biopharma plc Ordinary Shares NVET Stock Holding History

Glazer Capital LLC’s Portfolio NVET Stock Details NVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-42,605	Closed	-$284K	–	112
2017 Q2	$284K	Buy	+42,605	New	+$268K	0.02%	72

Glazer Capital LLC's NVET Position: Q3 2017 in Review

Glazer Capital LLC sold out of Nexvet Biopharma plc Ordinary Shares (NVET) in Q3 2017, closing a stake of 42,605 shares — an estimated $284K sold.

Glazer Capital LLC first reported a position in NVET in Q2 2017 and held it in 1 quarter. The position peaked at $284K in Q2 2017. 0 funds tracked by Wall St. Rank hold NVET as of Q3 2017.

Glazer Capital LLC reported no remaining Nexvet Biopharma plc Ordinary Shares position as of Q3 2017 after selling out during the quarter.
Glazer Capital LLC sold 42,605 Nexvet Biopharma plc Ordinary Shares shares in Q3 2017, an estimated $284K.
Glazer Capital LLC first reported a position in Nexvet Biopharma plc Ordinary Shares in Q2 2017 and held it in 1 quarter.
Glazer Capital LLC's Nexvet Biopharma plc Ordinary Shares position peaked at $284K in Q2 2017.
0 funds tracked by Wall St. Rank held Nexvet Biopharma plc Ordinary Shares as of Q3 2017.

Based on Glazer Capital LLC's 13F filing for Q3 2017, filed 14 Nov 2017.